A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults

Part of paid clinical trials in Rochester, New York.

Sponsor
Pfizer
Study ID
NCT07768345
Phase
PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Respiratory Syncytial Virus (RSV)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • RSVpreF Vaccine — BIOLOGICAL
    RSVpreF Vaccine

Study Details

The purpose of this phase 3 study is to learn the safety, tolerability and immunogenicity of revaccination with RSVpreF at approximately 1-, 2-, and 3-year intervals to inform the revaccination interval in immunocompromised adults. This study is seeking participants who are 18 years of age and older and will be grouped based on prior RSV vaccination history. Participants are required to be immunocompromised per study protocol. All participants in this study will receive 1 shot to their arm of a RSVPreF vaccine. Participants will take part in this study for about 12 months and will need to visit the clinical study site at least 4 times.

Key Dates

First listed
Aug 17, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Feb 2, 2028
Completion
Feb 2, 2028

Study Design

Enrollment
440 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Group 1
    RSVpreF Vaccine
  • Experimental: Group 2
    RSVpreF Vaccine
  • Experimental: Group 3
    RSVpreF Vaccine
  • Experimental: Group 4
    RSVpreF Vaccine

Primary Outcome Measure

Percentage of participants reporting local reactions [ Time Frame: For up to 7 days after vaccination ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rochester Clinical ResearchRochesterNew York14609-

Find similar trials in Rochester, NY

By research site
Rochester Clinical Research· Rochester, NY

Related Studies